Zdrowie i gospodarka · 10/01/2007

FDA Classifies Quality Control Material for Cystic Fibrosis Nucleic Acid Assays as Class II Device

The FDA is classifying quality control material for cystic fibrosis nucleic acid assays as a Class II device, requiring special controls to ensure the device's safety and effectiveness, with a guidance document available for review.